tiprankstipranks
Pliant Therapeutics highlights INTEGRIS-PSC Phase 2a data on bexotegrast
PremiumThe FlyPliant Therapeutics highlights INTEGRIS-PSC Phase 2a data on bexotegrast
3M ago
Aligos Therapeutics appoints Hardean Achneck as CMO
Premium
The Fly
Aligos Therapeutics appoints Hardean Achneck as CMO
4M ago
Pliant Therapeutics presents data from its Bexotegrast program
Premium
The Fly
Pliant Therapeutics presents data from its Bexotegrast program
4M ago
PLRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsPLRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago
Pliant Therapeutics announces data from 320 mg cohort of INTEGRIS-PSC
Premium
The Fly
Pliant Therapeutics announces data from 320 mg cohort of INTEGRIS-PSC
6M ago
Truist biotech analyst holds an analyst/industry conference call
Premium
The Fly
Truist biotech analyst holds an analyst/industry conference call
6M ago
Pliant Therapeutics price target lowered to $45 from $54 at RBC Capital
PremiumThe FlyPliant Therapeutics price target lowered to $45 from $54 at RBC Capital
9M ago
Pliant Therapeutics price target raised to $48 from $47 at Oppenheimer
Premium
The Fly
Pliant Therapeutics price target raised to $48 from $47 at Oppenheimer
9M ago
Pliant Therapeutics price target lowered to $36 from $48 at H.C. Wainwright
Premium
The Fly
Pliant Therapeutics price target lowered to $36 from $48 at H.C. Wainwright
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100